Inactive Instrument

News Hi-Tech Pharmacal Co.

Equities

US42840B1017

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Hi Tech Pharmacal : Akorn Completes Acquisition of Hi-Tech Pharmacal	17/14/17	BU
Hi Tech Pharmacal : Akorn Receives FTC Clearance for Hi-Tech Pharmacal Acquisition	15/14/15	BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal Reports Sales of $59.9 Million for the Third Quarter Ended January 31, 2014	11/14/11	BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal Receives Final Approval for Bromfenac Ophthalmic Solution, 0.09% (Once-A-Day)	23/14/23	BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal Announces Settlement Regarding Texas Pricing Investigation	26/13/26	BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal Reports Sales of $58.6 million for the Second Quarter Ended October 31, 2013	10/13/10	BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Release First Quarter Earnings and Hold Conference Call on September 9, 2013	06/13/06	BU
Hi-Tech Pharmacal Co. : HI-TECH PHARMACAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Hi-Tech Pharmacal Co., Inc. Following Announcement of Proposed Sale of Company to Akorn, Inc.	29/13/29	BU
Hi-Tech Pharmacal Co. : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Hi-Tech Pharmacal Co., Inc. Shareholders	28/13/28	BU
Hi-Tech Pharmacal Co. : Ryan & Maniskas, LLP Announces Investigation of Hi-Tech Pharmacal Co., Inc.	28/13/28	PR
Hi-Tech Pharmacal Co. : Akorn to Acquire Hi-Tech Pharmacal for $640 Million	27/13/27	BU
Hi-Tech Pharmacal Co. : Health Care Products Division of Hi-Tech Pharmacal Receives FDA Warning Letter Related to Labeling Statements on Certain OTC Products	24/13/24	BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Release Fourth Quarter Earnings and Hold Conference Call on July 9, 2013	03/13/03	BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Present at the Bank of America Merrill Lynch 2013 Health Care Conference	09/13/09	BU
Hi-Tech Pharmacal Co. : ECR Pharmaceuticals Announces Re-launch of Zolpimist® and DexPak®, Divestiture of Hylase® and Orbivan® Brands, and Dr. Cameron Durrant Named President and CEO	30/13/30	BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Present at the Needham 12th Annual Healthcare Conference	29/13/29	BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal Reports Sales of $64.3 Million and EPS of $0.43 for the Third Quarter Ended January 31, 2013	07/13/07	BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Release Third Quarter Earnings and Hold Conference Call on March 7, 2013	04/13/04	BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Present at the 2013 RBC Capital Markets' Healthcare Conference	27/13/27	BU
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Present at the Oppenheimer 23rd Annual Healthcare Conference	11/12/11	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Hi-Tech Pharmacal Co.

Equities

US42840B1017

Summary

Filters